Exposure | Outcome | Method | nSNP | Beta | SE | P | OR | 95% CI |
---|---|---|---|---|---|---|---|---|
COPD | Lung squamous carcinoma | IVW | 12 | 0.564 | 0.211 | 0.008 | 1.757 | 1.162–2.657 |
MR-Egger | 12 | 0.690 | 0.615 | 0.288 | 1.993 | 0.597–6.655 | ||
Weighted median | 12 | 0.519 | 0.247 | 0.036 | 1.680 | 1.036–2.724 | ||
MR-PRESSO | 12 | 0.149 | 0.458 | 0.752 | 1.160 | 0.472–2.849 | ||
Heart failure | IVW | 13 | 0.120 | 0.040 | 0.002 | 1.127 | 1.043–1.218 | |
MR-Egger | 13 | 0.161 | 0.093 | 0.114 | 1.174 | 0.978–1.410 | ||
Weighted median | 13 | 0.156 | 0.045 | 0.001 | 1.169 | 1.070-1.218 | ||
MR-PRESSO | 13 | 0.120 | 0.040 | 0.011 | 1.127 | 1.043-1.218 | ||
Osteoporosis | IVW | 13 | 0.179 | 0.073 | 0.014 | 1.197 | 1.037–1.381 | |
MR-Egger | 13 | 0.520 | 0.130 | 0.002 | 1.682 | 1.303–2.170 | ||
Weighted median | 13 | 0.179 | 0.073 | 0.030 | 1.197 | 1.037–1.381 | ||
MR-PRESSO | 13 | 0.212 | 0.080 | 0.008 | 1.236 | 1.056–1.447 | ||
Chronic periodontitis | IVW | 13 | 0.193 | 0.079 | 0.015 | 1.213 | 1.038–1.417 | |
MR-Egger | 13 | 0.379 | 0.179 | 0.057 | 1.461 | 1.030–2.073 | ||
Weighted median | 13 | 0.087 | 0.092 | 0.362 | 1.091 | 0.911–1.307 | ||
MR-PRESSO | 13 | 0.342 | 0.097 |  < 0.001 | 1.408 | 1.164–1.703 | ||
Chronic kidney disease | IVW | 12 | 0.176 | 0.054 | 0.001 | 1.193 | 1.072–1.326 | |
MR-Egger | 12 | 0.270 | 0.125 | 0.056 | 1.310 | 1.025–1.675 | ||
Weighted median | 12 | 0.193 | 0.068 | 0.005 | 1.213 | 1.061–1.387 | ||
MR-PRESSO | 12 | 0.176 | 0.054 | 0.008 | 1.193 | 1.072–1.326 |